Weekly Recap | Revolution Medicines -8.17%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:37 AMRVMD+1.59%
Weekly Recap | Moderna +18.41%, closing in on record highsWeekly Review·Oct 10, 2026 at 07:08 AMMRNA-5.50%MRNY-4.72%
Weekly Recap | Regeneron Pharma +1.54%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:34 AMREGN+2.60%
Weekly Recap | Amgen +2.94%, MariTide buzz lifts sharesWeekly Review·Oct 10, 2026 at 06:02 AMAMGN+0.39%
Weekly Recap | Vertex Pharma +1.06%, consensus target above spotWeekly Review·Oct 10, 2026 at 08:05 AMVRTX-0.18%
Weekly Recap | Gilead Sciences +4.44%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 06:37 AMGILD-0.41%
Weekly Recap | Alnylam Pharma +5.9%, consensus target above spotWeekly Review·Oct 10, 2026 at 06:02 AMALNY-2.07%
Weekly Recap | Moderna -4.46%, Citi cuts to SellWeekly Review·Oct 3, 2026 at 07:17 AMMRNA-5.50%MRNY-4.72%
Weekly Recap | Alnylam Pharma -14.16%, one-way sellingWeekly Review·Oct 3, 2026 at 08:28 AMALNY-2.07%
Weekly Recap | Gilead Sciences -4.1%, sliding toward range lowsWeekly Review·Oct 3, 2026 at 06:52 AMGILD-0.41%
Weekly Recap | Regeneron Pharma -6.71%, Sanofi alliance brings $1B upfrontWeekly Review·Oct 3, 2026 at 07:39 AMREGN+2.60%
Weekly Recap | AMGN.US -2.79%, consensus target above spotWeekly Review·Oct 3, 2026 at 06:18 AMAMGN+0.39%
Weekly Recap | Vertex Pharma this week, closing in on record highsWeekly Review·Oct 3, 2026 at 08:01 AMVRTX-0.18%
